packageCrizotinib
crizotinib
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Crizotinib is an ALK inhibitor anticancer drug used to treat non-small-cell lung carcinoma and other tumours such as inflammatory myofibroblastic tumour. It is authorised in the European Union and is an approved medicine, used mainly in oncology care.
Summary written by glm-5.3-flash from Wikidata Q5186964 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | crizotinib |
| ATC codes: | L01ED01 |
| DrugBank: | DB08865 |
| PubChem CID: | 11626560 |
| ChEBI: | 64310 |
| Wikidata: | Q5186964 |
| formula: | C21H22Cl2FN5O |
| molar mass: | 450.339 g/mol (PubChem CID 11626560) |
| logP: | 3.7 (Drugs.Common 25.09, not verified) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |